poisar

Stocks · News reference

Zymeworks Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance

Fiscal.ai

Zymeworks announced its financial results for the third quarter of 2026, reporting revenue of $256.5 million and earnings per share of $2.28, while raising its full-year 2026 financial guidance.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Zymeworks Inc. (ZYME)

    Filed: 2026-11-16 AccNo: 0001937653-26-000070 Size: 197 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits